
Valproic Acid (145mg) + Sodium Valproate (333mg)
Active composition
+1 more active ingredient
Valproic Acid increases GABA levels in the brain by inhibiting GABA transaminase, thereby reducing neuronal excitability and stabilizing electrical activity.
Sodium Valproate increases GABAergic neurotransmission, stabilizing neuronal excitability and reducing seizure activity.
Medical applications
The New Vat CR 500 Tablet is a pharmaceutical formulation designed primarily for the management of certain types of epilepsy, migraines, and bipolar disorder. It contains a combination of Sodium Valproate (333mg) and Valproic Acid (145mg). Sodium Valproate is a broad-spectrum antiepileptic, while Valproic Acid serves as a backbone for both antiepileptic and mood stabilizing properties. The CR in New Vat CR 500 stands for controlled-release, ensuring a steady state of the medication in the body throughout the day, thereby reducing the frequency of dosing. However, it is crucial to note that this medication should be used under the supervision of a healthcare provider due to its potential for serious side effects and the need for regular monitoring.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
New Vat CR 500 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
New Vat CR 500 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Medical Advice
New Vat CR 500 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of New Vat CR 500 Tablet may not be needed in these patients. Please consult your doctor. However, talk to your doctor if you have any underlying kidney disease.
Exercise Caution
New Vat CR 500 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
New Vat CR 500 Tablet should be used with caution in patients with liver disease. Dose adjustment of New Vat CR 500 Tablet may be needed. Please consult your doctor. Use of New Vat CR 500 Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for New Vat CR 500 Tablet

Sodium Valproate (333mg) + Valproic Acid (145mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Valproic Acid increases GABA levels in the brain by inhibiting GABA transaminase, thereby reducing neuronal excitability and stabilizing electrical activity.
Sodium Valproate increases GABAergic neurotransmission, stabilizing neuronal excitability and reducing seizure activity.
Medical applications
The New Vat CR 500 Tablet is a pharmaceutical formulation designed primarily for the management of certain types of epilepsy, migraines, and bipolar disorder. It contains a combination of Sodium Valproate (333mg) and Valproic Acid (145mg). Sodium Valproate is a broad-spectrum antiepileptic, while Valproic Acid serves as a backbone for both antiepileptic and mood stabilizing properties. The CR in New Vat CR 500 stands for controlled-release, ensuring a steady state of the medication in the body throughout the day, thereby reducing the frequency of dosing. However, it is crucial to note that this medication should be used under the supervision of a healthcare provider due to its potential for serious side effects and the need for regular monitoring.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
New Vat CR 500 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
New Vat CR 500 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Medical Advice
New Vat CR 500 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of New Vat CR 500 Tablet may not be needed in these patients. Please consult your doctor. However, talk to your doctor if you have any underlying kidney disease.
Exercise Caution
New Vat CR 500 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
New Vat CR 500 Tablet should be used with caution in patients with liver disease. Dose adjustment of New Vat CR 500 Tablet may be needed. Please consult your doctor. Use of New Vat CR 500 Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for New Vat CR 500 Tablet















